Skip to main content
Top
Published in: Cancer Causes & Control 4/2013

01-04-2013 | Original paper

The 2011–2016 Transdisciplinary Research on Energetics and Cancer (TREC) Initiative: Rationale and Design

Authors: Ruth E. Patterson, Graham A. Colditz, Frank B. Hu, Kathryn H. Schmitz, Rexford S. Ahima, Ross C. Brownson, Kenneth R. Carson, Jorge E. Chavarro, Lewis A. Chodosh, Sarah Gehlert, Jeff Gill, Karen Glanz, Debra Haire-Joshu, Karen Louise Herbst, Christine M. Hoehner, Peter S. Hovmand, Melinda L. Irwin, Linda A. Jacobs, Aimee S. James, Lee W. Jones, Jacqueline Kerr, Adam S. Kibel, Irena B. King, Jennifer A. Ligibel, Jeffrey A. Meyerhardt, Loki Natarajan, Marian L. Neuhouser, Jerrold M. Olefsky, Enola K. Proctor, Susan Redline, Cheryl L. Rock, Bernard Rosner, David B. Sarwer, J. Sanford Schwartz, Dorothy D. Sears, Howard D. Sesso, Meir J. Stampfer, S. V. Subramanian, Elsie M. Taveras, Julia Tchou, Beti Thompson, Andrea B. Troxel, Marianne Wessling-Resnick, Kathleen Y. Wolin, Mark D. Thornquist

Published in: Cancer Causes & Control | Issue 4/2013

Login to get access

Abstract

Purpose

Recognition of the complex, multidimensional relationship between excess adiposity and cancer control outcomes has motivated the scientific community to seek new research models and paradigms.

Methods

The National Cancer Institute developed an innovative concept to establish a center grant mechanism in nutrition, energetics, and physical activity, referred to as the Transdisciplinary Research on Energetics and Cancer (TREC) Initiative. This paper gives an overview of the 2011–2016 TREC Collaborative Network and the 15 research projects being conducted at the centers.

Results

Four academic institutions were awarded TREC center grants in 2011: Harvard University, University of California San Diego, University of Pennsylvania, and Washington University in St. Louis. The Fred Hutchinson Cancer Research Center is the Coordination Center. The TREC research portfolio includes three animal studies, three cohort studies, four randomized clinical trials, one cross-sectional study, and two modeling studies. Disciplines represented by TREC investigators include basic science, endocrinology, epidemiology, biostatistics, behavior, medicine, nutrition, physical activity, genetics, engineering, health economics, and computer science. Approximately 41,000 participants will be involved in these studies, including children, healthy adults, and breast and prostate cancer survivors. Outcomes include biomarkers of cancer risk, changes in weight and physical activity, persistent adverse treatment effects (e.g., lymphedema, urinary and sexual function), and breast and prostate cancer mortality.

Conclusion

The NIH Science of Team Science group will evaluate the value added by this collaborative science. However, the most important outcome will be whether this transdisciplinary initiative improves the health of Americans at risk of cancer as well as cancer survivors.
Literature
1.
go back to reference Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307:91–97CrossRef Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307:91–97CrossRef
2.
go back to reference Ogden CL, Carroll MD, Kit BK, Flegal KM (2012) Prevalence of obesity and trends in the distribution of body mass index among US children and adolescents. JAMA 307:83–90CrossRef Ogden CL, Carroll MD, Kit BK, Flegal KM (2012) Prevalence of obesity and trends in the distribution of body mass index among US children and adolescents. JAMA 307:83–90CrossRef
3.
go back to reference Finkelstein EA, Trogdon JG, Cohen JW, Dietz W (2009) Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 28(5):w822–w831CrossRef Finkelstein EA, Trogdon JG, Cohen JW, Dietz W (2009) Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 28(5):w822–w831CrossRef
4.
go back to reference Basen-Engquist K, Chang M (2011) Obesity and cancer risk: recent review and evidence. Curr Oncol Rep 13:71–76PubMedCrossRef Basen-Engquist K, Chang M (2011) Obesity and cancer risk: recent review and evidence. Curr Oncol Rep 13:71–76PubMedCrossRef
6.
go back to reference Pan SY, DesMeules M (2009) Energy intake, physical activity, energy balance, and cancer: epidemiologic evidence. Methods Mol Biol 472:191–215PubMedCrossRef Pan SY, DesMeules M (2009) Energy intake, physical activity, energy balance, and cancer: epidemiologic evidence. Methods Mol Biol 472:191–215PubMedCrossRef
7.
go back to reference Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3:565–574PubMedCrossRef Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3:565–574PubMedCrossRef
8.
go back to reference Winzer BM, Whiteman DC, Reeves MM, Paratz JD (2011) Physical activity and cancer prevention: a systematic review of clinical trials. Cancer Causes Control 22:811–826PubMedCrossRef Winzer BM, Whiteman DC, Reeves MM, Paratz JD (2011) Physical activity and cancer prevention: a systematic review of clinical trials. Cancer Causes Control 22:811–826PubMedCrossRef
9.
go back to reference Davies NJ, Batehup L, Thomas R (2011) The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer 1:S52–S73CrossRef Davies NJ, Batehup L, Thomas R (2011) The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer 1:S52–S73CrossRef
10.
go back to reference Friedenreich CM, Neilson HK, Lynch BM (2010) State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 46:2593–2604PubMedCrossRef Friedenreich CM, Neilson HK, Lynch BM (2010) State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 46:2593–2604PubMedCrossRef
11.
go back to reference Ballard-Barbash R, Hunsberger S, Alciati MH et al (2009) Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations. J Natl Cancer Inst 101:630–643PubMedCrossRef Ballard-Barbash R, Hunsberger S, Alciati MH et al (2009) Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations. J Natl Cancer Inst 101:630–643PubMedCrossRef
12.
go back to reference Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH (2010) An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surv 4:87–100CrossRef Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH (2010) An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surv 4:87–100CrossRef
13.
go back to reference Patterson RE, Cadmus LA, Emond JA, Pierce JP (2010) Physical activity, diet, adiposity and breast cancer prognosis: a review of the epidemiologic literature. Maturitas 66:5–15PubMedCrossRef Patterson RE, Cadmus LA, Emond JA, Pierce JP (2010) Physical activity, diet, adiposity and breast cancer prognosis: a review of the epidemiologic literature. Maturitas 66:5–15PubMedCrossRef
14.
go back to reference Schmitz KH, Courneya KS, Matthews C et al (2010) American college of sports medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426PubMedCrossRef Schmitz KH, Courneya KS, Matthews C et al (2010) American college of sports medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426PubMedCrossRef
15.
go back to reference Jones LW, Demark-Wahnefried W (2006) Diet, exercise, and complementary therapies after primary treatment for cancer. Lancet Oncol 7:1017–1026PubMedCrossRef Jones LW, Demark-Wahnefried W (2006) Diet, exercise, and complementary therapies after primary treatment for cancer. Lancet Oncol 7:1017–1026PubMedCrossRef
16.
go back to reference Hewitt M, Greenfield S, Stovall E (2006) From cancer patient to cancer survivor: lost in transition. The National Academies Press, Washington Hewitt M, Greenfield S, Stovall E (2006) From cancer patient to cancer survivor: lost in transition. The National Academies Press, Washington
17.
go back to reference Harvey AE, Lashinger LM, Hursting SD (2011) The growing challenge of obesity and cancer: an inflammatory issue. Ann NY Acad Sci 1229:45–52PubMedCrossRef Harvey AE, Lashinger LM, Hursting SD (2011) The growing challenge of obesity and cancer: an inflammatory issue. Ann NY Acad Sci 1229:45–52PubMedCrossRef
18.
go back to reference Gallagher EJ, Fierz Y, Ferguson RD, LeRoith D (2010) The pathway from diabetes and obesity to cancer, on the route to targeted therapy. Endocr Pract 16:864–873PubMedCrossRef Gallagher EJ, Fierz Y, Ferguson RD, LeRoith D (2010) The pathway from diabetes and obesity to cancer, on the route to targeted therapy. Endocr Pract 16:864–873PubMedCrossRef
19.
go back to reference Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301–316PubMedCrossRef Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301–316PubMedCrossRef
20.
go back to reference Tsugane S, Inoue M (2010) Insulin resistance and cancer: epidemiological evidence. Cancer Sci 101:1073–1079PubMedCrossRef Tsugane S, Inoue M (2010) Insulin resistance and cancer: epidemiological evidence. Cancer Sci 101:1073–1079PubMedCrossRef
21.
go back to reference Lynch BM, Neilson HK, Friedenreich CM (2011) Physical activity and breast cancer prevention. Recent Results Cancer Res 186:13–42PubMedCrossRef Lynch BM, Neilson HK, Friedenreich CM (2011) Physical activity and breast cancer prevention. Recent Results Cancer Res 186:13–42PubMedCrossRef
22.
go back to reference Stokols D, Hall KL, Taylor BK, Moser RP (2008) The science of team science. Overview of the field and introduction to the supplement. Am J Prev Med 35:S77–S89PubMedCrossRef Stokols D, Hall KL, Taylor BK, Moser RP (2008) The science of team science. Overview of the field and introduction to the supplement. Am J Prev Med 35:S77–S89PubMedCrossRef
23.
go back to reference Croyle RT (2008) The National Cancer Institute’s transdisciplinary centers initiatives and the need for building a science of team science. Am J Prev Med 35:S90–S93PubMedCrossRef Croyle RT (2008) The National Cancer Institute’s transdisciplinary centers initiatives and the need for building a science of team science. Am J Prev Med 35:S90–S93PubMedCrossRef
24.
go back to reference Warnecke RB, Oh A, Breen N, Gehlert S, Paskett E, Tucker KL, Lurie N, Rebbeck T, Goodwin J, Flack J, Srinivasan S, Kerner J, Heurtin-Roberts S, Abeles R, Tyson FL, Patmios G, Hiatt RA (2008) Approaching health disparities from a population perspective: the National Institutes of Health Centers for population health and health disparities. Am J Public Health 98(9):1608–1615PubMedCrossRef Warnecke RB, Oh A, Breen N, Gehlert S, Paskett E, Tucker KL, Lurie N, Rebbeck T, Goodwin J, Flack J, Srinivasan S, Kerner J, Heurtin-Roberts S, Abeles R, Tyson FL, Patmios G, Hiatt RA (2008) Approaching health disparities from a population perspective: the National Institutes of Health Centers for population health and health disparities. Am J Public Health 98(9):1608–1615PubMedCrossRef
25.
go back to reference Abrams DB, Leslie F, Mermelstein R, Kobus K, Clayton RR (2003) Transdisciplinary tobacco use research. Nicotine Tob Res 5(Suppl 1):S5–S10PubMedCrossRef Abrams DB, Leslie F, Mermelstein R, Kobus K, Clayton RR (2003) Transdisciplinary tobacco use research. Nicotine Tob Res 5(Suppl 1):S5–S10PubMedCrossRef
26.
go back to reference Hall KL, Stokols D, Stipelman BA, Vogel AL, Feng A, Masimore B, Morgan G, Moser RP, Marcus SE, Berrigan D (2012) Assessing the value of team science: a study comparing center- and investigator-initiated grants. Am J Prev Med 42(2):157–163PubMedCrossRef Hall KL, Stokols D, Stipelman BA, Vogel AL, Feng A, Masimore B, Morgan G, Moser RP, Marcus SE, Berrigan D (2012) Assessing the value of team science: a study comparing center- and investigator-initiated grants. Am J Prev Med 42(2):157–163PubMedCrossRef
27.
go back to reference Rimer BK, Abrams DB (2012) Present and future horizons for transdisciplinary research. Am J Prev Med 42(2):200–201PubMedCrossRef Rimer BK, Abrams DB (2012) Present and future horizons for transdisciplinary research. Am J Prev Med 42(2):200–201PubMedCrossRef
28.
go back to reference Vogel AL, Feng A, Oh A, Hall KL, Stipelman B, Okamoto J, Stokols D, Moser RP, Perna F, Nebeling L (2012) Influences of a National Cancer Institute transdisciplinary research and training initiative on trainees’ transdisciplinary research competencies and scholarly productivity. Transl Behav Med 4(2):459–468 Vogel AL, Feng A, Oh A, Hall KL, Stipelman B, Okamoto J, Stokols D, Moser RP, Perna F, Nebeling L (2012) Influences of a National Cancer Institute transdisciplinary research and training initiative on trainees’ transdisciplinary research competencies and scholarly productivity. Transl Behav Med 4(2):459–468
29.
go back to reference Stokols D, Hall KL, Vogel AL (2012) Transdisciplinary public health: definitions, core characteristics, and strategies for success. In: Haire-Joshu D, McBride TD (eds) Transdisciplinary public health: research, methods, and practice. Jossey-Bass, San Francisco Stokols D, Hall KL, Vogel AL (2012) Transdisciplinary public health: definitions, core characteristics, and strategies for success. In: Haire-Joshu D, McBride TD (eds) Transdisciplinary public health: research, methods, and practice. Jossey-Bass, San Francisco
30.
go back to reference Hall KL, Stokols D, Moser RP et al (2008) The collaborative readiness of transdisciplinary research teams and centers. Findings from the National Cancer Institute’s TREC year-one evaluation study. Am J Prev Med 35:S161–S172PubMedCrossRef Hall KL, Stokols D, Moser RP et al (2008) The collaborative readiness of transdisciplinary research teams and centers. Findings from the National Cancer Institute’s TREC year-one evaluation study. Am J Prev Med 35:S161–S172PubMedCrossRef
31.
go back to reference Neuhouser ML, Schwartz Y, Wang C, Breymeyer K, Coronado G, Wang CY, Noar K, Song X, Lampe JW (2012) A low-glycemic load diet reduces serum C-reactive protein and modestly increases adiponectin in overweight and obese adults. J Nutr 142(2):369–374PubMedCrossRef Neuhouser ML, Schwartz Y, Wang C, Breymeyer K, Coronado G, Wang CY, Noar K, Song X, Lampe JW (2012) A low-glycemic load diet reduces serum C-reactive protein and modestly increases adiponectin in overweight and obese adults. J Nutr 142(2):369–374PubMedCrossRef
32.
go back to reference Behan JW, Yun JP, Proektor MP, Ehsanipour EA, Arutyunyan A, Moses AS, Avramis VI, Louie SG, Butturini A, Heisterkamp N, Mittelman SD (2009) Adipocytes impair leukemia treatment in mice. Cancer Res 19:7867–7874CrossRef Behan JW, Yun JP, Proektor MP, Ehsanipour EA, Arutyunyan A, Moses AS, Avramis VI, Louie SG, Butturini A, Heisterkamp N, Mittelman SD (2009) Adipocytes impair leukemia treatment in mice. Cancer Res 19:7867–7874CrossRef
33.
go back to reference Campbell PT, Gross MD, Potter JD, Schmitz KH, Duggan C, McTiernan A, Ulrich CM (2010) Effect of exercise on oxidative stress: a 12-month randomized, controlled trial. Med Sci Sports Exerc 42(8):1448–1453PubMedCrossRef Campbell PT, Gross MD, Potter JD, Schmitz KH, Duggan C, McTiernan A, Ulrich CM (2010) Effect of exercise on oxidative stress: a 12-month randomized, controlled trial. Med Sci Sports Exerc 42(8):1448–1453PubMedCrossRef
34.
go back to reference Thompson CL, Larkin EK, Patel S, Berger NA, Redline S, Li L (2011) Short duration of sleep increases risk of colorectal adenoma. Cancer 117(4):841–847PubMedCrossRef Thompson CL, Larkin EK, Patel S, Berger NA, Redline S, Li L (2011) Short duration of sleep increases risk of colorectal adenoma. Cancer 117(4):841–847PubMedCrossRef
35.
go back to reference Arikawa AY, O’Dougherty M, Kaufman B, Thomas W, Warren M, Kurzer M, Schmitz KH (2010) Women in steady exercise research (WISER): study design and methods. Contemp Clin Trials 31:457–465PubMedCrossRef Arikawa AY, O’Dougherty M, Kaufman B, Thomas W, Warren M, Kurzer M, Schmitz KH (2010) Women in steady exercise research (WISER): study design and methods. Contemp Clin Trials 31:457–465PubMedCrossRef
36.
go back to reference Arikawa AY, Kurzer MS, Thomas W, Schmitz KH (2010) No effect of exercise on insulin-like growth factor (IGF)-1, insulin and glucose in young women participating in a 16-week randomized controlled trial. Cancer Epidemiol Biomark Prev 19:2987–2990CrossRef Arikawa AY, Kurzer MS, Thomas W, Schmitz KH (2010) No effect of exercise on insulin-like growth factor (IGF)-1, insulin and glucose in young women participating in a 16-week randomized controlled trial. Cancer Epidemiol Biomark Prev 19:2987–2990CrossRef
37.
go back to reference Arikawa AY, Thomas W, Schmitz KH, Kurzer MS (2011) Sixteen weeks of exercise reduces C-reactive protein levels in young women. Med Sci Sports Exerc 43:1002–1009PubMedCrossRef Arikawa AY, Thomas W, Schmitz KH, Kurzer MS (2011) Sixteen weeks of exercise reduces C-reactive protein levels in young women. Med Sci Sports Exerc 43:1002–1009PubMedCrossRef
38.
go back to reference Smith AJ, Phipps WR, Arikawa AY, O’Dougherty M, Kaufman B, Thomas W, Schmitz KH, Kurzer MS (2011) Effects of aerobic exercise on premenopausal sex hormone levels: results of the WISER study, a randomized clinical trial in healthy, sedentary, eumenorrheic women. Cancer Epidemiol Biomark Prev 20:1098–1106CrossRef Smith AJ, Phipps WR, Arikawa AY, O’Dougherty M, Kaufman B, Thomas W, Schmitz KH, Kurzer MS (2011) Effects of aerobic exercise on premenopausal sex hormone levels: results of the WISER study, a randomized clinical trial in healthy, sedentary, eumenorrheic women. Cancer Epidemiol Biomark Prev 20:1098–1106CrossRef
39.
go back to reference Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Grant LL, Bryan CJ, Williams-Smith CT, Greene QP (2009) Weight lifting in women with breast cancer-related lymphedema. New Engl J Med 361:664–673PubMedCrossRef Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Grant LL, Bryan CJ, Williams-Smith CT, Greene QP (2009) Weight lifting in women with breast cancer-related lymphedema. New Engl J Med 361:664–673PubMedCrossRef
40.
go back to reference Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, Bryan CJ, Williams-Smith CT, Chittams J (2010) Weight-lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA 304:2699–2705PubMedCrossRef Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, Bryan CJ, Williams-Smith CT, Chittams J (2010) Weight-lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA 304:2699–2705PubMedCrossRef
Metadata
Title
The 2011–2016 Transdisciplinary Research on Energetics and Cancer (TREC) Initiative: Rationale and Design
Authors
Ruth E. Patterson
Graham A. Colditz
Frank B. Hu
Kathryn H. Schmitz
Rexford S. Ahima
Ross C. Brownson
Kenneth R. Carson
Jorge E. Chavarro
Lewis A. Chodosh
Sarah Gehlert
Jeff Gill
Karen Glanz
Debra Haire-Joshu
Karen Louise Herbst
Christine M. Hoehner
Peter S. Hovmand
Melinda L. Irwin
Linda A. Jacobs
Aimee S. James
Lee W. Jones
Jacqueline Kerr
Adam S. Kibel
Irena B. King
Jennifer A. Ligibel
Jeffrey A. Meyerhardt
Loki Natarajan
Marian L. Neuhouser
Jerrold M. Olefsky
Enola K. Proctor
Susan Redline
Cheryl L. Rock
Bernard Rosner
David B. Sarwer
J. Sanford Schwartz
Dorothy D. Sears
Howard D. Sesso
Meir J. Stampfer
S. V. Subramanian
Elsie M. Taveras
Julia Tchou
Beti Thompson
Andrea B. Troxel
Marianne Wessling-Resnick
Kathleen Y. Wolin
Mark D. Thornquist
Publication date
01-04-2013
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 4/2013
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0150-z

Other articles of this Issue 4/2013

Cancer Causes & Control 4/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine